Carlyle Group makes strategic growth investment in Pharmapacks

NEW YORK — Pharmapacks announced on Thursday a strategic investment of more than $250 million from global investment firm The Carlyle Group to accelerate the company’s growth plans. The growth investment places Pharmapacks’ enterprise value at approximately $1.1 billion. Pharmapacks was founded as a single brick and mortar pharmacy and has since evolved into a platform